RadNet earnings release, May 11, 2026
RadNet Reports Record First Quarter Financial
Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
LOS ANGELES, California, May 10, 2026 – RadNet,
Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 435 outpatient imaging centers and a premier developer of radiology digital health solutions, today reported financial results for its first quarter of 2026.
Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “After being impacted by severe winter weather conditions in the Northeast during January and February which reduced Revenue and Adjusted EBITDA
Financial statements
Income Statement
Imaging Center Segment
| Original Guidance Range | Revised Guidance Range | |
|---|---|---|
| Total Net Revenue | $2,325 - $2,375 million | $2,355 - $2,405 million |
| Adjusted EBITDA(1) | $335 - $348 million | $340 - $353 million |
| Capital Expenditures(a) | $165 - $175 million | $165 - $175 million |
| Cash Interest Expense(b) | $45 - $50 million | $45 - $50 million |
| Free Cash Flow(2) | $105 - $115 million | $112 - $122 million |
Income Statement
Digital Health Segment
| Original Guidance Range | Revised Guidance Range | |
|---|---|---|
| Total Net Revenue | $135 - $145 million | $135 - $145 million |
| Adjusted EBITDA(1) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $10 - $12 million | $10 - $12 million |
| Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $17 - $19 million | $17 - $19 million |
| Capital Expenditures | $9 - $12 million | $9 - $12 million |
| Free Cash Flow(2) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $(1) - $3 million | $(1) - $3 million |
| Free Cash Flow(2) After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI | $(17) - $(19) million | $(17) - $(19) million |
Income Statement
Three Months Ended March 31, — (unaudited) (in thousands)
| Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 | ||
|---|---|---|---|
| Service fee revenue | 545,218 | 439,349 | |
| Revenue under capitation arrangements | 30,413 | 32,050 | |
| Total service revenue | 575,631 | 471,399 | |
| OPERATING EXPENSES | Cost of operations, excluding depreciation and amortization | 550,512 | 453,480 |
| OPERATING EXPENSES | Lease abandonment charges | 5,388 | |
| OPERATING EXPENSES | Depreciation and amortization | 44,967 | 35,483 |
| OPERATING EXPENSES | Loss (gain) on sale and disposal of equipment and other | 2,591 | 402 |
| OPERATING EXPENSES | Severance costs | 1,464 | 747 |
| OPERATING EXPENSES | Total operating expenses | 599,534 | 495,500 |
| OPERATING EXPENSES | INCOME (LOSS) FROM OPERATIONS | -23,903 | -24,101 |
| OTHER INCOME AND EXPENSES | Interest expense | 17,657 | 17,239 |
| OTHER INCOME AND EXPENSES | Equity in earnings of joint ventures | -3,825 | -2,599 |
| OTHER INCOME AND EXPENSES | Non-cash change in fair value of interest rate hedge | 2,106 | |
| OTHER INCOME AND EXPENSES | Other (income) expenses | -4,907 | -7,712 |
| OTHER INCOME AND EXPENSES | Total other (income) expenses | 8,925 | 9,034 |
| OTHER INCOME AND EXPENSES | INCOME (LOSS) BEFORE INCOME TAXES | -32,828 | -33,135 |
| OTHER INCOME AND EXPENSES | Provision for income taxes | 8,096 | 3,398 |
| OTHER INCOME AND EXPENSES | NET INCOME (LOSS) | -24,732 | -29,737 |
| OTHER INCOME AND EXPENSES | Net income (loss) attributable to noncontrolling interests | 8,734 | 8,189 |
| OTHER INCOME AND EXPENSES | NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -33,466 | -37,926 |
| OTHER INCOME AND EXPENSES | BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -0.43 | -0.51 |
| OTHER INCOME AND EXPENSES | DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -0.43 | -0.51 |
| WEIGHTED AVERAGE SHARES OUTSTANDING | Basic | 77,057,835 | 74,382,356 |
| WEIGHTED AVERAGE SHARES OUTSTANDING | Diluted | 77,057,835 | 74,382,356 |
Income Statement
Three Months Ended March 31, — (unaudited) (in thousands)
| Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025(iv) | ||
|---|---|---|---|
| NET LOSS INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -33,466 | -37,926 | |
| Add Non-cash change in fair value of interest rate hedges (i) | 2,106 | ||
| Add Non-operational rent expenses (iii) | 900 | 1,342 | |
| Add Acquisition transaction costs | 3,454 | 672 | |
| Add loss on sale and disposal of equipment and other | 2,591 | 402 | |
| Add Severance costs | 1,464 | 747 | |
| Add Lease abandonment charges | 5,388 | ||
| Add Change to contingent consideration | 2,764 | ||
| Add Non-capitalized R&D - DeepHealth cloud OS & generative AI | 4,560 | 3,562 | |
| Total adjustments - loss (gain) | 15,733 | 14,219 | |
| Subtract tax impact of Adjustments (ii) | -3,880 | -1,459 | |
| Tax effected impact of adjustments | 11,853 | 12,760 | |
| TOTAL ADJUSTMENT TO NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS | 11,853 | 12,760 | |
| ADJUSTED NET LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -21,613 | -25,166 | |
| WEIGHTED AVERAGE SHARES OUTSTANDING | Diluted | 77,057,835 | 74,382,356 |
| WEIGHTED AVERAGE SHARES OUTSTANDING | ADJUSTED DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -0.28 | -0.34 |
Balance Sheet
March 31, 2026 — (IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)
| March 31, 2026 – (unaudited) | December 31, 2025 | ||
|---|---|---|---|
| CURRENT ASSETS | Cash and Cash equivalents | 455,339 | 767,215 |
| CURRENT ASSETS | Accounts receivable | 209,090 | 200,317 |
| CURRENT ASSETS | Due from affiliates | 11,033 | 12,592 |
| CURRENT ASSETS | Prepaid expenses and other current assets | 65,313 | 52,003 |
| CURRENT ASSETS | Total current assets | 740,775 | 1,032,127 |
| PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS | Property and equipment, net | 862,057 | 807,702 |
| PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS | Operating lease right-of-use assets | 760,975 | 690,250 |
| PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS | Total property, plant, equipment and right-of-use assets | 1,623,032 | 1,497,952 |
| OTHER ASSETS | Goodwill | 1,094,699 | 907,663 |
| OTHER ASSETS | Other intangible assets | 253,481 | 148,508 |
| OTHER ASSETS | Deferred financing costs | 1,538 | 1,684 |
| OTHER ASSETS | Investment in joint ventures | 131,409 | 130,340 |
| OTHER ASSETS | Deposits and other | 40,455 | 40,289 |
| OTHER ASSETS | Total Assets | 3,885,389 | 3,758,563 |
| CURRENT LIABILITIES | Accounts payable, accrued expenses and other | 454,602 | 422,029 |
| CURRENT LIABILITIES | Due to affiliates | 75,960 | 70,104 |
| CURRENT LIABILITIES | Deferred revenue | 11,975 | 7,272 |
| CURRENT LIABILITIES | Current operating lease liability | 66,591 | 61,934 |
| CURRENT LIABILITIES | Current portion of notes payable | 26,506 | 25,424 |
| CURRENT LIABILITIES | Total current liabilities | 635,634 | 586,763 |
Cash Flow
Three Months Ended March 31, — (unaudited) (in thousands)
| Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 | ||
|---|---|---|---|
| Net loss | -24,732 | -29,737 | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Depreciation and amortization | 44,967 | 35,483 |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Noncash operating lease expense | 16,298 | 14,431 |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Equity in earnings of joint ventures, net of dividends | -1,069 | -2,599 |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Amortization of deferred financing costs and loan discount | 779 | 728 |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Loss on sale and disposal of equipment | 2,591 | 402 |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Lease abandonment charges | 5,388 | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Amortization of cash flow hedge | 1,033 | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Non-cash change in fair value of interest rate swap | 2,106 | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Stock-based compensation | 31,375 | 28,494 |
| Adjustments to reconcile net loss to net cash provided by operating activities: | Change in fair value of contingent consideration | -2,764 | |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Accounts receivable | 9,375 | -14,306 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Other current assets | -6,172 | -7,206 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Other assets | -660 | -1,691 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Deferred taxes | -9,099 | 5,137 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Operating leases | -13,299 | -21,968 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Deferred revenue | 234 | 128 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Accounts payable, accrued expenses and other | 31,148 | 25,658 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions: | Net cash provided by operating activities | 78,972 | 41,481 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Purchase of imaging facilities and other acquisitions, net of cash acquired | -304,151 | -3,794 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Purchase of property and equipment and other | -69,932 | -48,833 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Proceeds from sale of equipment | 277 | 23 |
| CASH FLOWS FROM INVESTING ACTIVITIES | Equity contributions in existing and purchase of interest in joint ventures | -4,147 | |
| CASH FLOWS FROM INVESTING ACTIVITIES | Collection of notes receivable | 2,833 | |
| CASH FLOWS FROM INVESTING ACTIVITIES | Net cash used in investing activities | -370,973 | -56,751 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Principal payments on notes and leases payable | -9,953 | -1,718 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Payments on Term Loan Debt | -5,252 | -5,000 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Distributions paid to noncontrolling interests | -2,402 | -913 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Proceeds from issuance of common stock upon exercise of options | 103 | 121 |
| CASH FLOWS FROM FINANCING ACTIVITIES | Net cash used in financing activities | -17,504 | -7,510 |
| CASH FLOWS FROM FINANCING ACTIVITIES | EFFECT OF EXCHANGE RATE CHANGES ON CASH | -2,371 | 83 |
| CASH FLOWS FROM FINANCING ACTIVITIES | NET DECREASE IN CASH AND CASH EQUIVALENTS | -311,876 | -22,697 |
| CASH FLOWS FROM FINANCING ACTIVITIES | CASH AND CASH EQUIVALENTS, beginning of period | 767,215 | 740,020 |
| CASH FLOWS FROM FINANCING ACTIVITIES | CASH AND CASH EQUIVALENTS, end of period | 455,339 | 717,323 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | Cash paid during the period for interest | 17,073 | 18,010 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | Cash paid during the period for income taxes | 519 | 272 |
Full release
(1) by an estimated $13 million and $9 million, respectively, our business strongly rebounded in March, resulting in a Total Company Revenue increase of 22.1% and a Total Company Adjusted EBITDA
(1) increase of 36.3% from last year’s first quarter. The record first quarter performance was driven by aggregate advanced imaging (MRI, CT and PET/CT) growth of 19.7% and same-center advanced imaging growth of 8.2% as compared with the first quarter of last year. The growth in MR, CT and PET/CT contributed to a 235 basis point shift in RadNet’s advanced imaging procedural volume mix (relative to routine imaging) as compared with the same quarter last year, increasing from 26.9% in last year’s first quarter to 29.3% in the first quarter of 2026. Imaging
Center Adjusted EBITDA
(1) margin increased by 52 basis points, after adjusting for lost Revenue and Adjusted EBITDA
(1) from the severe winter weather in this year’s first quarter and the severe winter weather and California wildfires in last year’s first quarter.”
Dr. Berger continued, “On April 30th, we announced the commencement of a new health system joint venture with Trinity Health’s Saint Alphonsus Health System initially with five outpatient imaging centers in Boise, Idaho. In conjunction with this new partnership, various modules of DeepHealth OS as well as AI-powered solutions for radiologist reporting, patient engagement and clinical interpretation will be implemented. This relationship is a blueprint for future health system partnerships, where RadNet can bring all of its operational, clinical and digital workflow solutions to bear to streamline the patient journey and improve medical care and outcomes. As a result of the strong operating trends during the first quarter which have continued through early May, we are increasing 2026 Imaging Center guidance for Revenue, Adjusted EBITDA
(1) and Free Cash Flow
(2).”
“The Digital Health division continues to gain momentum, which was further advanced with the March 2, 2026 acquisition of Gleamer SAS in France. DeepHealth’s clinical AI portfolio now includes interpretive solutions in virtually all imaging modalities. We estimate that by the end of this year, over 70% of RadNet studies could be running through clinical AI, and we expect that all of RadNet’s radiologist reports will be processed through DeepHealth’s
Reporting Pro AI-powered auto-impression/summarization engine. When fully implemented, these initiatives should result in significant enhancement to patient care and workflow productivity intended to achieve a measurable improvement to RadNet’s operating expenses.
Furthermore, the Digital Health sales pipeline with third-party customers continued to build during the first quarter, during which we signed over $16 million (Total Contract Value) of new DeepHealth business. These contracts span the full breadth of DeepHealth products including clinical AI, operating and diagnostic workflow and TechLive solutions,” added Dr. Berger.
“RadNet’s balance sheet continues to be among the strongest in the diagnostic imaging industry. At quarter end, which reflected the acquisition of Gleamer and recent imaging center transactions, we had a cash balance of $455.3 million and a leverage ratio of Net Debt to Adjusted EBITDA
(1) of slightly below 2.0. Financial leverage and liquidity will continue to be carefully managed to maintain optimal future operating flexibility,” concluded Dr. Berger.
Financial Results
For the first quarter of 2026, RadNet reported Total
Company Revenue of $575.6 million and Adjusted EBITDA
(1) of $63.3 million. Revenue increased $104.2 million (or 22.1%) and
Adjusted EBITDA
(1) increased $16.9 million (or 36.3%) as compared with the first quarter of 2025.
For the first quarter of 2026, RadNet reported Digital
Health Revenue (inclusive of intersegment revenue) of $29.1 million and Adjusted EBITDA
(1) of $1.3 million. Revenue increased
$9.9 million (or 51.5%) and Adjusted EBITDA
(1) decreased $2.4 million as compared with the first quarter of 2025. At March 31, 2026, Annual Recurring Revenue
(4)
(ARR) for Digital Health was $96.9 million, as compared with $49.8 million as of March 31, 2025.
There were a number of unusual or one-time items impacting the first quarter including: $0.9 million expense related to leases for de novo facilities under construction that have yet to open their operations; $3.5 million of acquisition transaction costs; $2.6 million loss on the sale and disposal of equipment; $1.5 million of severance costs; $2.8 million change in contingent consideration related to past acquisitions; and $4.6 million of non-capitalized research and development expenses with respect to DeepHealth Cloud OS and generative AI. Adjusting for the above items, Total Company Adjusted Loss
(3) was $21.6 million and diluted Adjusted Loss Per Share
(3) was $(0.28) for the first quarter of 2026. This compares with Total
Company Adjusted Loss
(3) of $25.2 million and diluted Adjusted Loss Per Share
(3) of $(0.34) during the first quarter of 2025.
Unadjusted for unusual or one-time items impacting... (truncated) 2026, Total Company Net Loss for the first quarter of 2026 was $33.5 million as compared with a Total Company Net
Loss of $37.9 million for the first quarter of 2025. Net Loss Per Share for the first quarter of 2026 was $(0.43), compared with a Net
Loss per share of $(0.51) in the first quarter of 2025, based upon a weighted average number of diluted shares outstanding of 77.1 million shares in 2026 and 74.4 million shares in 2025.
For the first quarter of 2026, as compared with the prior year’s first quarter, MRI volume increased 20.3%, CT volume increased 17.7% and PET/CT volume increased 35.2% on a systemwide basis (including unconsolidated joint venture centers). Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 10.1% over the prior year’s first quarter. On a same-center systemwide basis, including only those centers which were part of RadNet for both the first quarters of 2026 and 2025, MRI volume increased 10.0%, CT volume increased 4.7% and PET/CT volume increased 14.7%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 2.4% over the prior year’s same quarter.
2026 Revised Guidance
RadNet amends its previously announced guidance levels as follows:
Imaging Center Segment
Digital Health Segment
Financial Results Conference Call
Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its first quarter 2026 results on Monday, May 11th, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Conference Call Details:
Date: Monday, May 11, 2026
Time: 10:30 a.m. Eastern Time
Dial In-Number: 844-744-1280
International Dial-In Number: 412-564-6465
It is recommended that participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1761306&tp_key=ea5d61284c or http://www.radnet.com under the “Investors” menu section and “News Releases” sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international allers, and using the passcode 10208825.
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona,
California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at radnet.com.
Forward Looking Statements
This press release contains
“forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform
Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,”
“believe,” “project,” “estimate,” “expect,” “strategy,” “future,”
“likely,” “may,” “should,” “will” and similar references to future periods.
Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.
Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information concerning risks, uncertainties and assumptions can be found in RadNet's filings with the SEC, including the risk factors discussed in RadNet's most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC.
Any forward-looking statement contained in this release is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.
Regulation G: GAAP and Non-GAAP Financial Information
This release contains certain financial information... (truncated)ompany believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.
CONTACTS:
RadNet, Inc.
Mark Stolper, 310-445-2800
Executive Vice President and Chief Financial
Officer